Cohance Lifesciences Limited
COHANCE
Classifica tra le azioni
#6386
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Prezzo delle azioni
$5.05
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$1.93B
Variazione (1 giorno)
-1.44%
Variazione (1 anno)
-57.38%
Paese
IN
Scambia Cohance Lifesciences Limited (COHANCE)
Categoria
Healthcare
Rapporto P/S per Cohance Lifesciences Limited (COHANCE)
Rapporto P/S al October 2026 TTM: 75.08
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Cohance Lifesciences Limited, il rapporto P/S attuale (TTM) è 75.08. Alla fine del 2024, era pari a 16.21.
Storico del rapporto P/S per Cohance Lifesciences Limited da 2019 a 2026
Rapporto P/S alla fine di ogni anno
| Anno | Rapporto P/S | Cambia |
|---|---|---|
| 2026 (TTM) | 75.08 | 232.64% |
| 2025 | 22.57 | 39.25% |
| 2024 | 16.21 | 80.67% |
| 2023 | 8.97 | -26.49% |
| 2022 | 12.21 | -5.42% |
| 2021 | 12.91 | 306.97% |
| 2020 | 3.17 | -72.93% |
| 2019 | 11.71 | 0.00% |
Rapporto P/S per aziende simili o concorrenti
| Azienda | Rapporto P/S | Differenza del rapporto P/S | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -90.60% |
IN
|
